A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
PARP 抑制剂的比较药代动力学研究表明,尼拉帕尼在临床前肿瘤模型中具有良好的疗效
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26354
Kaiming Sun, Keith Mikule, Zebin Wang, Grace Poon, Aparajitha Vaidyanathan, Gillian Smith, Zhi-Yi Zhang, Jeffrey Hanke, Sridhar Ramaswamy, Jing Wang